OUTCOME OF CHILDREN WITH NON HIGH RISK NEUROBLASTOMA TREATED IN NORTHERN EGYPT

被引：0
|
作者：
Alsheikh, H. [1 ]
Mashali, N. [2 ]
Badawy, H. [3 ]
Abd-Elkarem, A. [4 ]
Fadel, S. [1 ]
机构：
[1] Fac Med, Pediat Oncol Unit, Alexandria, Egypt
[2] Fac Med, Dept Pathol, Alexandria, Egypt
[3] Fac Med, Dept Urol, Alexandria, Egypt
[4] Fac Med, Diagnost & Intervent Radiol, Alexandria, Egypt
来源：
PEDIATRIC BLOOD & CANCER | 2015年 / 62卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P-359
引用
收藏
页码：S327 / S327
页数：1
相关论文
共 50 条
  • [41] Dental abnormalities in children treated for neuroblastoma
    Kaste, SC
    Hopkins, KP
    Bowman, LC
    Santana, VM
    MEDICAL AND PEDIATRIC ONCOLOGY, 1998, 30 (01): : 22 - 27
  • [42] Factors for scoliosis in children treated for neuroblastoma
    Paulino, AC
    Fowler, BZ
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2004, 60 (01): : S565 - S565
  • [43] Influence of carrier cells on the clinical outcome of children with neuroblastoma treated with high dose of oncolytic adenovirus delivered in mesenchymal stem cells
    Melen, Gustavo J.
    Franco-Luzon, Lidia
    Ruano, David
    Gonzalez-Murillo, Africa
    Alfranca, Arantzazu
    Casco, Fernando
    Lassaletta, Alvaro
    Alonso, Mercedes
    Madero, Luis
    Alemany, Ramon
    Garcia-Castro, Javier
    Ramirez, Manuel
    CANCER LETTERS, 2016, 371 (02) : 161 - 170
  • [44] Survival Outcome of Intermediate Risk Neuroblastoa at Children's Cancer Hospital of Egypt
    Fawzy, M.
    Elzomor, H.
    Ahmed, G.
    Elmenawi, S.
    Elkinaai, N.
    Refaat, A.
    Soliman, S.
    Amr, M.
    Zaghloul, M.
    PEDIATRIC BLOOD & CANCER, 2018, 65 : S248 - S249
  • [45] Non-High-Risk Neuroblastoma: Classification and Achievements in Therapy
    Meany, Holly J.
    CHILDREN-BASEL, 2019, 6 (01):
  • [46] Outcome of children with relapsed high-risk neuroblastoma in Japan and analysis of the role of allogeneic hematopoietic stem cell transplantation
    Hara, Junichi
    Nitani, Chika
    Shichino, Hiroyuki
    Kuroda, Tatsuo
    Hishiki, Tomoro
    Soejima, Toshinori
    Mori, Tetsuya
    Matsumoto, Kimikazu
    Sasahara, Yoji
    Iehara, Tomoko
    Miyamura, Takako
    Kosaka, Yoshiyuki
    Takimoto, Tetsuya
    Nakagawara, Akira
    Tajiri, Tatsuro
    JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 2022, 52 (05) : 486 - 492
  • [47] Physeal Abnormalities in Children With High-risk Neuroblastoma Intensively Treated With/Without 13-Cis-Retinoic Acid
    Koh, Kyung-Nam
    Jeon, Ji Young
    Park, Soo-Sung
    Im, Ho Joon
    Kim, Hyery
    Kang, Michael Seungcheol
    JOURNAL OF PEDIATRIC ORTHOPAEDICS, 2021, 41 (09) : E841 - E848
  • [48] Improved Outcome in Children With Newly Diagnosed High-Risk Neuroblastoma Treated With Chemoimmunotherapy: Updated Results of a Phase II Study Using hu14.18K322A
    Furman, Wayne L.
    McCarville, Beth
    Shulkin, Barry L.
    Davidoff, Andrew
    Krasin, Matthew
    Hsu, Chia-Wei
    Pan, Haitao
    Wu, Jianrong
    Brennan, Rachel
    Bishop, Michael W.
    Helmig, Sara
    Stewart, Elizabeth
    Navid, Fariba
    Triplett, Brandon
    Santana, Victor
    Santiago, Teresa
    Hank, Jacquelyn A.
    Gillies, Stephen D.
    Yu, Alice
    Sondel, Paul M.
    Leung, Wing H.
    Pappo, Alberto
    Federico, Sara M.
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (04) : 335 - +
  • [49] Telomere Maintenance Mechanisms Define Clinical Outcome in High-Risk Neuroblastoma
    Koneru, Balakrishna
    Lopez, Gonzalo
    Farooqi, Ahsan
    Conkrite, Karina L.
    Nguyen, Thinh H.
    Macha, Shawn J.
    Modi, Apexa
    Rokita, Jo Lynne
    Urias, Eduardo
    Hindle, Ashly
    Davidson, Heather
    Mccoy, Kristyn
    Nance, Jonas
    Yazdani, Vanda
    Irwin, Meredith S.
    Yang, Shengping
    Wheeler, David A.
    Maris, John M.
    Diskin, Sharon J.
    Reynolds, C. Patrick
    CANCER RESEARCH, 2020, 80 (12) : 2663 - 2675
  • [50] Renal toxicity in paediatric patients with high-risk neuroblastoma treated with radiotherapy
    Gomis Selles, E.
    Burgueno Caballero, A. M.
    Munoz Munoz, O.
    Delgado Leon, B. D.
    Cabrera Roldan, P.
    RADIOTHERAPY AND ONCOLOGY, 2022, 170 : S1220 - S1222
12345